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presenting with alarm symptoms at index gastroscopy. In addition we analysed our data to
see if there was a significant association between alarm symptoms and the presence or
absence of gastric malignancy using the Fishers exact two-tailed test. Results Gastric ulcers
were reported in 553 patients and of these 371 (67%) presented with alarm symptoms. A
total of 33 (6%) malignancies were detected histologically. Of the 33 gastric malignancies
diagnosed 21 (64%) adenocarcinomas, 5 (15%) lymphomas, 3 (9%) poorly differentiated
carcinomas, 2 (6%) squamous cell carcinomas and 2 (6%) carcinoid were found. Off the
371 patients with alarm symptoms 26 (7%) had cancer. Of the 182 patients without alarm
symptoms 7 (4%) had a gastric malignancy. In patients with gastric ulcers there was not a
statistically significant difference between the presence of alarm symptoms in predicting the
presence of gastric malignancy on histology (p=0.133). Of the patients with gastric ulcers
166 (30%) had Helicobacter pylori. Conclusion These results confirm that alarm symptoms
are not useful as positive predictors of gastric malignancy in patients who are known to
have gastric ulcer. In our series 21% of the gastric malignancies were in the group undergoing
gastroscopy for non-alarm symptoms.
W1074
Determinants of Bloating Severity: Symptomatic and Psychosocial Factors
Influencing the Impactfullness of Bloating
Michael P. Jones, Jason Bratten, Sarah Umar, Laurie Keefer, Michael D. Crowell
Purpose: HRQOL and symptom severity are commonly assessed in FGID. We developed
and validated an FGID-specific instrument assessing QOL related to bloating (Bloating
Symptom Impact Scale [BSIS]; Am J Gastro 102:S505). This study prospectively evaluated
symptom and psychosocial factors influencing BSIS in FGID pts with bloating as a dominant
symptom. Methods: Rome II FD and IBS pts with bloating as a dominant complaint were
recruited through the NU and MCS GI Clinic. Pts completed the B-SIS along with a general
QOL measure (SF-12) and a GI symptom questionnaire (GISSI). Patients also completed
measures of generalized anxiety and depression (HADS), visceral-specific anxiety (Visceral
Sensitivity Index; VSI), and negative affect/hostility (Type D personality: DS14). Univariate
analysis identified factors significantly correlated with B-SIS and symptoms of upper and
lower abdominal bloating. These candidate factors were then entered into regression analysis.
Results: 62 pts (mean(SD)age=49(18)yrs; 79%F) were studied. With the exception of gender
and BMI, all candidate variables were significantly correlated with BSIS. Upper abdominal
bloating (UAB) was significantly correlated with VSI (r=-0.5; p=0.000), BSIS (r=-0.38; p=
0.004), SF12PhysicalRole (r=-0.36; p=0.006), lower abdominal bloating (LAB)(r=0.47; p=
0.000) as well as symptoms of abdominal fullness (r=0.54; p=0.000) and flatulence (r=0.38;
p=0.002). Regression analysis identified a 3-step model in which fullness, CP and flatus
explained 43% of UAB variance. LAB was correlated with VSI (r=0.55; p=0.000), BSIS (r=-
0.51; p=0.000), UAB and symptoms of flatulence (r=0.6; p=0.000), straining (r=0.48; p=
0.000), abdominal fullness (r=0.46; p=0.000) and pelvic pain (r=0.46; p=0.000). Regression
analysis identified a 3-step model in which flatulence, fullness and pelvic pain explained
58% of LAB variance. Stepwise regression for BSIS identified a 4-step model (Table) in
which VSI, HADS-D, LAB and age explained 66% of BSIS variance. Conclusion: Symptoms
of upper and lower abdominal bloating are associated with reduced general and condition-
specific QOL.While symptom reporting was independent ofmeasured psychosocial variables,
BSIS was significantly influenced by visceral-specific anxiety and depression. Psychosocial
comorbidities have profound implications both in clinical practice and research settings
seeking to use QOL as a therapeutic endpoint.
W1075
Intolerance to Volume Load in Drink Test and Psychiatric Distress Enhance
the Severity of Daily Dyspeptic Symptoms in Functional Dyspepsia
Koji Nakada, Motohiro Ozone, Shigeru Harasawa, Naruo Kawasaki, Tomoko Nakayoshi,
Nobuyoshi N. Hanyu, Hideyuki Kashiwagi, Katsuhiko Yanaga
Underlying causes of symptoms in functional dyspepsia (FD) are multi-factorial, including
delayed gastric emptying, impaired gastric accommodation, visceral hypersensitivity and
psychiatric distress (PD). However, the impact of these abnormal gastric physiology and
psychiatric distress on the severity of daily dyspeptic symptoms (DS), and the correlation
among these causes are still unclear. Aims: To examine the impact of abnormal gastric
physiology and psychiatric distress on the severity of daily DS, and to examine the correlation
among these multi-factorial causes in FD. Methods: Thirty-three FD (Rome II) patients were
evaluated by gastric emptying study (GE; 13C-acetate breath test with liquid meal [200
kcal/200 ml]) and drink test (DT; drink 10ml/kg of water for 5 minutes at equal rate).
Subjects also completed STAI, SDS, CMI and the original dyspeptic symptoms questionnaire
to examine DS severity (strength and frequency). The correlation between DS severity with
GE, DT, and PD were examined. The correlation among GE, DT, and PD were also examined.
Results: In FD, delayed gastric emptying (27%), intolerance to volume load in DT (88%),
and psychiatric distress assessed by STAI-state (64%), SDS (46%), and CMI (73%) were
noted. No correlation existed between DS severity and GE, whereas both DT and PD
correlated significantly with DS severity (p<0.05). No correlation existed between GE with
DT and PD, whereas significant correlation was noted between DT and PD (p<0.05). Conclu-
sions: In FD, both intolerance to volume load in DT and PD enhanced DS severity. DT is
a simple and non-invasive method and correlated well with DS severity, which therefore
may be appropriate for routine clinical use to determine abnormal gastric physiology.
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How the Duration of Dyspeptic Symptom Affect the Therapeutic Approaches.
Experience from Japanese Mega Study (Jmms)
Koji Nakada, Michio Hongo, Shigeru Harasawa, Tetsuya Mine, Iwao Sasaki, Kei
Matsueda, Motoyasu Kusano, Nobuyoshi N. Hanyu, Chikashi Shibata
Rome III redefined the diagnostic criteria of functional dyspepsia (FD), modifying the
subgroups, symptom (S) categories, symptom duration (SD), from Rome II. This change is
more suitable to clinical use in practice. However, there are many dyspeptic patients in
practice who do not fulfill the duration criteria. To clarify the importance of SD for the
diagnostic criteria, we analyzed the characteristics of the patients enrolled to clinical trials
for dyspeptic patients conducted in Japan, called JMMS. JapanMosaprideMega-Study (JMMS)
was conducted to explore the best treatment to such patients, led by Japan-International
Society for Gastrointestinal Motility, and is a nationwide cooperative study in FD patients.
A total of 1.027 of 1,042 patients having feeling of gastric stasis and/or epigastric pain with
frequency > 2 times/week, duration > 2 weeks, had endoscope. Of these, 424 patients were
excluded due to the presence of organic lesion in the EGD, S resolution after assurance by
negative endoscopy or patients' personal reasons. The remaining 618 patients were allocated
to two treatment groups; mosapride (5HT4 agonist) group and teprenon (gastric mucosa
protectant) group. Each group had phamacotherapy for 2 weeks. [Methods] 1.027 patients
were classified into 4 groups according to SD; A (n=146), <1 month (M); B (n=352), 1 to
<3 M; C (n=267), 3 to <12 M; and D (n=262), >12 M. Age, gender, S subtypes, S scores
(summation of S frequency and severity) and patients' impression were analyzed. [Results]
D were; younger and more male dominant than the other groups, while A were youngest
in mean age. Prevalence of subtypes and S scores were statistically similar each other. S
resolution after assurance of negative endoscopy was 35% in A, 35% in B, 21% in C and
29% in D. Reduction in S scores were 3.4, 3.1, 3.1 and 2.9 with mosapride (5mg tid) in
A, B, C and D, respectively, and 3.7, 1.9, 2.0 and 1.8 with teprenon (50mg tid), after 2
weeks of treatment. Significant difference between mosapride and teprenon was found in
B, C and D (p<0.001). Patients' impression with “Much improved”, “Improved” and “slightly
improved” were; 56, 58, 73 and 70% with mosapride in A, B, C and D, while those were
45, 30, 24 and 22% with teprenon. Significant difference was found in the B, C, and D
(p<0.005). [Conclusion] S severity and subtypes are not different according to SD. Longer
the SD, S resolution after negative endoscopy is less. However, symptomatic improvement
was not different among those who have SD >1 M. This indicate that the patients with SD
1 to <3 M are similar to the patients with SD >3 M (which meet Rome III) in terms of
response to therapeutic approaches.
W1077
The Long-Term Effect of Helicobacter pylori Eradication Therapy On
Dyspepsia Symptoms in Industrial Workers in Japan
Yukinao Yamazaki, Ikumi Yoshida, Akiyo Yamakawa, Hidetaka Matsuda, Takashi Ohno,
Ryuho Masaki, Satoko Satomi, Masahiro Ohtani, Hiroyuki Suto, Yoshiyuki Ito, Takuji
Kato, Takeshi Azuma
Background and Aim: The relationship between Helicobacter pylori (H. pylori) infection and
Functional dyspepsia (FD) is still controversial. The potential benefits and the potential risks
of the treatment could depend on local conditions, such as the prevalence of the infection
and the local rates of gastric cancer and other relevant diseases. The long-term effect of H.
pylori eradication therapy on functional dyspepsia has not been evaluated sufficiently. The
aim of this study is to investigate the long-term effect of H. pylori eradication therapy on
dyspepsia symptoms in industrial workers. Materials and Methods: Two hundred and ninety-
five of H. pylori -positive industrial workers were enrolled in this study. H. pylori infection
was diagnosed by serological test or urea breath test. The serum pepsinogen(PG) levels, PGI
value and PGI/II ratio, were measured. Atrophic gastritis was diagnosed by PGI value and
PGI/II ratio, ( < PGI 70ng/ml and < PGI/II 3.0). Seven dyspepsia symptoms, upper abdominal
pain, heart burn, regurgitation, nausea vomiting, upper abdominal fullness and loss of
appetite were examined by symptom scores. Symptom scores were also analyzed 3, 6,
12month and 5years after H. pylori eradication therapy. Ninety eradicated cases without
peptic ulcer history and fifty-two not eradicated cases without it suffered from some dyspepsia
symptoms. After all, one hundred and forty-two cases, ninety eradicated cases and fifty-two
not eradicated ones, were analyzed. Moreover, incidence of the gastro-duodenal diseases
during the study period was investigated. Results: The symptom scores of upper abdominal
pain, regurgitation, nausea, vomiting and loss of appetite improved significantly in the cured
cases. In short, the eradicated group showed improvement of dyspepsia symptoms compared
with the not eradicated group at the time point of 5 years. The serum PG levels did not
significantly related with or without the eradication therapy. In addition, the incidence rate
of the gastro-duodenal diseases was 2.0% (2/130) in the eradicated cases (gastric cancer 1,
gastric ulcer 1) and 9.5% (6/63) in the not eradicated ones (gastric cancer 1, gastric ulcer
3, duodenal ulcer 2). (p<0.05) The eradicated group showed significantly decreased incidence
of the gastro-duodenal diseases compared with the not eradicated one during the study
period. Conclusion: The cure of H. pylori infection provides a beneficial effect on dyspepsia
symptoms and the incidence of the gastro-duodenal diseases in industrial workers in Japan.
W1078
High Prevalence of Helicobacter pylori Infections By Multiple Strains in
Patients with Dyspepsia from a Developing Country
Shahab Abid, Javed Yakoob, Wasim Jafri, Khalid Mumtaz, Nida Jafri, Zaigham Abbas,
Hasnain Shah, Saeed S. Hamid, Rashida Ahmed
BACKGROUND: No convincing evidence has been found that eradication of Helicobacter
pylori (H. pylori) relieves the symptoms of functional dyspepsia 12 months after treatment.
Diversity in genotypes of Helicobacter pylori (H. pylori) have been reported with varying
results in different areas of the world. AIM: The aim of this study was to investigate the
prevalence of multiple strain infection in a symptomatic Pakistan population and to correlate
it with endoscopic and histological findings. METHODS: Patients with dyspeptic symptoms
with H. pylori were enrolled. C-14 Urea breath test and rapid urease test were done to
confirm the presence of H. pylori infection before the enrollment. Gastric biopsies from both
antrum and body were taken for rapid urease test, histology and polymerase chain reaction-
restriction fragment length polymorphism analysis (PCR-RFLP). Forward primer (5'-
TGGGACTGATGGCGTGAGGG -3') and reverse primer (5'-AAGGGCGTTTTTAGATTTTT
-3') prepared from the urease gene C gene were used to amplify 820 bp gene product and
Sau-3 and Hha I restriction enzymes for RFLP analysis. RESULTS: There were ninety-five
patients with 68 (72%) males. On endoscopy, 53(56%) had gastric antral and 39(41%) had
pangastric erythema. and 3(3%) had duodenal ulcer. H. pylori associated chronic active
gastritis on histology was present in 76(80%). PCR-RFLP patterns were similar in 77(81%)
on both antrum and body and different in 18(19 %). On endoscopy, antral gastric erythema
was present in 44(79%) with same RFLP pattern from both antrum and body and 12(21%)
with different RFLP patterns, while pangastric erythema was present in 33(85%) with same
RFLP pattern and 6(15%) with different RFLP patterns on bothsides (p=0.46).On histology,
chronic active gastritis was associated in 61(79%) patients with single RFLP pattern and in
15(83%) with different H. pylori strain (p=0.69) on both antrum and body. Patients with
corpus dominant gastritis had chronic active gastritis in 16(21%) with single RFLP pattern
and 3(17%) with multiple RFLP patterns p=0.89. CONCLUSION: Almost one fifth of
dyspeptic patients had H. pylori infection with more than one strain in our series. This might
contribute to lack of response to treatment especially in patients having H. pylori infection
with multiple strains.
W1079
Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or
An Agonist of Vanilloid Receptor?
Antonio Nouvenne, Andrea Maini, Lucas Giovanni Cavallaro, Roberta Merli, Loredana
Guida, Ester Morana, Margherita Curlo, Andrea Iori, Laura Martelli, Mario Martelli, Giulia
Martina Cavestro, Iva Pelosini, Carmelo Scarpignato, Angelo Franzè, Francesco Di Mario
INTRODUCTION: Functional dyspepsia is an very frequent disease. Up to now many
treatments are been proposed with conflicting results. Curcumin, the main element of
turmeric powder extract from Curcuma Longa, shows both antinflammatory and antioxidant
properties. Infact it is an agonist of vanilloid receptor(TRPV1)which plays a critical role in
thermal nociception and inflammatory hyperalgesia. Domperidon is a dopamine antagonist
currently used for treatment of dyspepsia. AIMS: To evaluate if a two months therapy
schedule based on Curcumin or Domperidon is effective on:1)symptoms relief.2) gastric
inflammation assessed by means of serum pepsinogen II in functional dyspepsia. MATERIALS
AND METHODS:48 consecutive H. pylori negative patients (17 M, mean age 47,7±13 years,
range 20-72) with functional dyspepsia, according with Rome III Criteria, were enrolled
from January to December 2006. Patients after informed consent were randomized in two
groups to take t.i.d. for 2 months: A tablet, containing curcumin 30 mg, Zn++-acetate 15
mg, bovine lactoferrin 100mg (LF-500, Dicofarm, Rome, Italy) (Group A, 27 pts)or Domperi-
don 10 mg (Group B, 21 pts). Upper GI symptoms were assessed and scored by administering
a validated questionnaire (Veldhuyzen S. APT.2006;23:521-9) at baseline (T0) and after two
months(T1). Gastro-oesophageal mucosal integrity and H. pylori status were assessed by
upper endoscopy with histology (five biopsies histologically classified according with the
Sydney System) and a blood sample for serum pepsinogens (sPGI,sPGII), gastrin-17(G-17)
and anti-Helicobacter IgG (IgG-Hp) (EIA,Biohit,Helsinki,Finland). RESULTS: There was a
significant decrease in the global overall symptoms both in Group A and in Group B (Group
A: T0: 17.6±4.6, T1: 10.77±3.44, p< 0.001; Group B: T0 17.19±4.49, T1 12.79±3.44
p<0.001). sPGII levels decreased inGroup A in a statistically significantmanner (T0: 14.7±5.7;
T1: 10.13±2.15, p=0.003)but not in Group B. sPGI,IgG and G-17 values did not significantly
decrease after two months. CONCLUSION: Curcumin as well Domperidon is effective on
improving dyspeptic symptoms. Curcumin but not Domperidon seems to reduce gastric
inflammation assessed by serological marker according with its properties in improving the
TNF cascade events. Further studies are necessary to confirm this results.
W1080
The Accuracy and Predictors of a Clinical Diagnosis of Dyspepsia or Peptic
Ulcer Disease By Gastroenterologists and Family Practitioners
Nimish Vakil, John Dent, Roger Jones, Tore Lind, Ola Junghard
Aim: To determine the accuracy of a clinical diagnosis of dyspepsia or peptic ulcer disease
compared to an endoscopy and/or abnormal pH-metry. Methods: Consecutive pts presenting
to primary care practices with any upper gastrointestinal (GI) symptoms thought to be of
upper GI tract origin were studied. Pts were evaluated by the family practitioner (FP) and
a diagnosis was recorded. Pts were then evaluated by a gastroenterologist (GE) and a
diagnosis was recorded. Physicians were blinded to each other's diagnoses. Within 7 days,
pts underwent upper endoscopy with Bravo pH-metry. A 24-hour period from midnight
on day 1 to midnight on day 2 was used to evaluate acid exposure. Pts were considered to
have GERD if either erosive esophagitis was present or if distal acid exposure was >5.5%
(or Symptom Association Probability (SAP) was 95% or more). Endoscopic findings that
were considered abnormal for this analysis were: erosive esophagitis, duodenal or gastric
ulcers or erosions. Results. 308 pts with upper GI symptoms were evaluated and 18 (6%)
and 6 (2%) were diagnosed with peptic ulcer disease by the FP and GE, respectively. In
these pts, a peptic ulcer was present in 4 of 18 pts (22%) diagnosed by FPs and 2 of 6 pts
(33%) diagnosed by GEs. When functional dyspepsia was diagnosed, endoscopy and pH-
metry (including SAP) were negative in 44 of 112 pts (39%) diagnosed as functional dyspepsia
and 8 of 18 pts (44%) diagnosed as peptic ulcer disease by FPs. Corresponding values for
GEs were 48 of 116 pts (41%) and 2 of 6 pts (33%), respectively. Table I shows the
sensitivity, specificity, positive and negative predictive values for a clinical diagnosis of
functional dyspepsia and peptic ulcer disease by FPs and GEs. Conclusions: (1) The clinical
diagnosis of functional dyspepsia and peptic ulcer disease is unreliable. (2) GERD is often
misdiagnosed as functional dyspepsia or peptic ulcer disease in primary care and gastroenter-
ology evaluations.
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Non-Digestible Capsule Technology to Measure Gastric Motility- Comparison
Between Healthy Controls and Gastroparetic Patients with a Normal Gastric
Empyting Study
Savio Reddymasu, Irene Sarosiek, Henry P. Parkman, Kenneth L. Koch, Michael D. Sitrin,
John M. Wo, William L. Hasler, Leonard A. Katz, William D. Chey, Jack Semler, Braden
Kuo, Richard McCallum
Introduction: The SmartPilltm wireless pH and pressure recording capsule has been recently
approved by the Food and Drug Administration to assess gastric emptying. Sometimes
patients referred to gastroenterologists with typical gastroparetic symptoms have a normal
gastric emptying assessed by scintigraphy (GES). Hence, the aims of this study were to
determine whether differences could be identified in gastric motility (number of contractions
per minute of gastric motor activity) using data obtained from the SmartPilltm pressure
measurements between normal subjects and patients with symptoms suggestive of gastropar-
esis but whose scintigraphic gastric emptying was normal. Methods: In a multicenter trial,
after an overnight fast, 108 subjects (Healthy-66, History of GP-38; DM16, idiopathic-22)
swallowed the SmartPilltm capsule, and then ingested a 99m Eggbeater meal (2% fat) and
had a standardized 4 hour measurement of gastric emptying. At the completion of the study
pressure, and pH data were analyzed. The GET was measured as the difference between
the time of ingestion of the capsule to an abrupt and sustained rise of pH to >4 and at least
3 pH units above baseline indicating duodenal arrival of the capsule. Frequencies of gastric
contractions expressed as number of contractions per minute (cpm) were calculated for the
entire duration of the GET beginning after intake of the SmartPilltm capsule and ending
when duodenal arrival was documented. GES was considered abnormal if >10% of the
radio-labeled meal was retained in the stomach at the end of 4 hours. A two tailed unequal
variance t-test was used for statistical analysis, and a p < 0.05 was considered significant.
95% confidence intervals (CI) were also calculated. Results: 22/38 (10 diabetics) patients
with a history of GP had a normal GES and were included for statistical analysis. Mean
frequency of gastric contractions in healthy controls was 1.7 cpm (1.5-1.9), was significantly
higher (p-0.005) compared to patients with a history of gastroparesis and normal GES 1.3
cpm (1.1-1.5). Conclusions: 1.) Gastric contraction frequency data analyzed from combining
motility data obtained from both the postprandial period and that associated with emptying
of a non-digestible capsule using the SmartPilltm pressure sensor can identify impaired
gastric motility in patients suspected of gastroparesis, although their GES may be normal
on the day of the study. 2.) SmartPilltm is a novel, safe, and non-invasive technology suitable
for use in the office setting to provide data regarding gastric motility with a patient friendly
technique that can be used to make decisions regarding medical therapy.
W1082
Lack of Discriminant Value of Dyspepsia Subgroups According to the ROME
III Consensus in Dyspeptic Patients On Acid-Suppressive Therapy Referred
for Upper Gastrointestinal Endoscopy
Sebastien Kindt, Joris Arts, Stefan Bourgeois, Christophe Claessens, Philip Caenepeel,
Lieselot Holvoet, Dominiek De Wulf, Raf Bisschops, Gert A. Van Assche, Severine
Vermeire, Jan F. Tack
Background: According to the Rome 3 consensus, functional dyspepsia(FD) is subcategorized
into Postprandial Distress Syndrome(PDS) and Epigastric Pain Syndrome(EPS). It has been
presumed that underlying pathophysiology differs between both groups, and that acid-
related mechanisms are more likely in EPS(comprising epigastric pain and burning) than
in PDS(comprising early satiation and postprandial fullness). We reported that EPS is associ-
ated with a higher prevalence of erosive eosphagitis in patients not on anti-secretory therapy
who were referred for open access endoscopy(Arts, DDW 2008). Our aim was to investigate
whether the Rome 3 subdivision identifies more acid-related lesions at endoscopy in dyspeptic
patients who are on acid-suppressive drugs. Methods: Consecutive patients referred for
open-access endoscopy for dyspeptic symptoms, persisting during empirical anti-secretory
therapy(PPI >1month), were recruited. All patients filled out demographic, Rome 3 dyspepsia
and heartburn word-picture questionnaires. The symptom pattern was used to identify EPS,
PDS and persisting heartburn according to established criteria. Results: 197 patients(mean
age 53.4±1.2, 80 men) participated. Criteria for PDS and EPS were fulfilled by respectively
130(66%) and 120(61%) patients, with overlap in 98(50%). In 44 patients(22%), the
symptom pattern did not fulfil Rome 3 criteria for EPS or PDS. Co-existing heartburn was
present in 62 patients(32%), with similar overlap in PDS and EPS(both 38%). Erosive
esophagitis was found in 40% of patients, mainly grade A(28%) and B(8%). A hiatal hernia,
Barrett's esophagus and peptic ulcer were found in respectively 47, 24 and 10 patients, and
no cancers were detected. The prevalence of erosive esophagitis did not differ significantly
between patients who fulfilled EPS criteria compared to those who did not(44% vs. 33%,
NS), nor for PDS versus non-PDS(42% vs. 38%, NS). The prevalence of esophagitis did not
differ between patients with or without positive heartburn word-picture questionnaire(47%
vs. 37%, NS), but the prevalence of hiatal hernia was higher in heartburn positive
patients(34% vs. 20%, p<0.05). Conclusion: In contrast to findings in patients who are not
on acid-suppressive therapy, the Rome 3 subdivison does not identify subgroups with a
different prevalence of erosive esophagitis in dyspepsia. As the higher prevalence of hiatal
hernia is higher in PDS, distinctive symptom or endoscopic features may be lost during
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